Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 3,704 | N/A | N/A | N/A |
| TOTAL | $4,507 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 4,675 | N/A | N/A | N/A |
| Other Non-Current Assets | 154 | 0 | 0 | 0 |
| TOTAL | $4,829 | $N/A | $N/A | $N/A |
| Total Assets | $9,336 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 9,706 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 11,972 | 0 | 0 | 0 |
| Accrued Expenses | 3,253 | N/A | N/A | N/A |
| TOTAL | $26,718 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 8,414 | N/A | N/A | N/A |
| Deferred Revenues | 1,787 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 9,276 | 0 | 0 | 0 |
| TOTAL | $38,629 | $N/A | $N/A | $N/A |
| Total Liabilities | $65,347 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -148,354 | N/A | N/A | N/A |
| Other shareholders' equity | -47 | 0 | 0 | 0 |
| TOTAL | $-56,011 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $9,336 | $0 | $0 | $0 |